Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph phase_1
3
43%
Ph phase_3
1
14%
Ph phase_2
1
14%
Ph phase_4
2
29%

Phase Distribution

3

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (42.9%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 42 (28.6%)

Trials by Status

completed7100%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_1

dMAbs for Prevention of COVID-19

NCT05293249
completedphase_2

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

NCT01987609
completedphase_4

Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics

NCT01139294
completedphase_1

The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers

NCT02654522
completedphase_1

A Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase

NCT00435604
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05293249Phase 1

dMAbs for Prevention of COVID-19

Completed
NCT01987609Phase 2

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

Completed
NCT01139294Phase 4

Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics

Completed
NCT02654522Phase 1

The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers

Completed
NCT00435604Phase 1

A Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase

Completed
NCT00593281Phase 3

INFUSE Morphine Study

Completed
NCT00311519Phase 4

A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7